These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 12952940)
1. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. Topol L; Jiang X; Choi H; Garrett-Beal L; Carolan PJ; Yang Y J Cell Biol; 2003 Sep; 162(5):899-908. PubMed ID: 12952940 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells. Helmbrecht K; Kispert A; von Wasielewski R; Brabant G Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224 [TBL] [Abstract][Full Text] [Related]
3. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Ishitani T; Kishida S; Hyodo-Miura J; Ueno N; Yasuda J; Waterman M; Shibuya H; Moon RT; Ninomiya-Tsuji J; Matsumoto K Mol Cell Biol; 2003 Jan; 23(1):131-9. PubMed ID: 12482967 [TBL] [Abstract][Full Text] [Related]
4. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574 [TBL] [Abstract][Full Text] [Related]
5. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Sakanaka C; Weiss JB; Williams LT Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208 [TBL] [Abstract][Full Text] [Related]
6. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853 [TBL] [Abstract][Full Text] [Related]
7. Wnt-independent beta-catenin transactivation in tumor development. Lu Z; Hunter T Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603 [TBL] [Abstract][Full Text] [Related]
8. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. Golan T; Yaniv A; Bafico A; Liu G; Gazit A J Biol Chem; 2004 Apr; 279(15):14879-88. PubMed ID: 14747478 [TBL] [Abstract][Full Text] [Related]
9. Wnt signaling and cancer. Polakis P Genes Dev; 2000 Aug; 14(15):1837-51. PubMed ID: 10921899 [No Abstract] [Full Text] [Related]
10. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768 [TBL] [Abstract][Full Text] [Related]
11. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. Papkoff J; Aikawa M Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782 [TBL] [Abstract][Full Text] [Related]
12. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785 [TBL] [Abstract][Full Text] [Related]
13. Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene. Ziemer LT; Pennica D; Levine AJ Mol Cell Biol; 2001 Jan; 21(2):562-74. PubMed ID: 11134343 [TBL] [Abstract][Full Text] [Related]
14. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Seeling JM; Miller JR; Gil R; Moon RT; White R; Virshup DM Science; 1999 Mar; 283(5410):2089-91. PubMed ID: 10092233 [TBL] [Abstract][Full Text] [Related]
15. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436 [TBL] [Abstract][Full Text] [Related]
16. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355 [TBL] [Abstract][Full Text] [Related]
17. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734 [TBL] [Abstract][Full Text] [Related]